Afyounian EbrahimComputational Analysis of Multilevel High-throughput Data from Cancer Tissue https://urn.fi/URN:ISBN:978-952-03-3224-2 2024-01-12 Eerola SiniThe Role of PIM Kinases in Prostate Cancer : Promoting and Inhibiting Factors https://urn.fi/URN:ISBN:978-952-03-2316-5 2022-03-11 Kimmo KartasaloComputational methods provide new tools for pathologists http://urn.fi/URN:ISBN:978-952-03-1953-3 May 21, 2021 |
Tommi RantaperoDeveloping a Framework for Analysis of Next-Generation Sequencing Data in Cancer Genetics and Epigenetics |
Kalle KaapuAntiarrythmic Drugs and Cancer In Finnish Men : An epidemiological study on prostate cancer risk, survival and overall cancer mortality |
Thea VeitonmäkiNon-steroidal anti-inflammatory drugs and cancer in Finnish men. An epidemiologic study on prostate cancer risk, survival and overall cancer mortality |
Virpi LaitinenGenetic risk factors for hereditary prostate cancer in Finland – From targeted analysis of susceptibility loci to genome-wide copy number variation study |
Riikka NurminenGenetic Susceptibility Factors for Prostate Cancer at Chromosomal Region 11q13.5 |
Mauro ScaravilliIdentification of 1p21-22 Amplification in Bladder Cancer and Expression of non-coding RNAs in Prostate Cancer |
Sanna SiltanenContribution of the ARLTS1 Gene to Prostate Cancer Susceptibility |
Tuomas KilpeläinenPopulation-Based Screening for Prostate Cancer – Weighing up the beneficial and adverse effects of screening |
Saara LehmusvaaraTraditional and Novel Treatments for Prostate Cancer – Discoveries at the molecular level |
Sanni JalavaThe role of 8q amplification and microRNAs in prostate cancer |
Alfonso UrbanucciOverexpression of Androgen Receptor in Prostate Cancer |
Teemu TolonenMolecular biomarkers and histopathological parameters in prostate cancer diagnostics and prognostics |
Sanna PakkanenProfiling of High-risk Prostate Cancer Families in Finland |
Kati Kivinummi (nee. Waltering)Androgen receptor signaling pathway in prostate cancer |
Teemu MurtolaProstate cancer incidence among men using statins, finasteride or antidiabetic drugs. |
Henna MattilaHereditary prostate cancer in Finland – From genetic linkage to susceptibility genes. |
Hanna RauhalaDNA hypermethylation in prostate cancer. |
Sari LaitinenProstate cancer: from molecular genetics to prognostic markers |
Tuukka MäkinenThe Finnish population-based prostate cancer screening trial. |
Liisa MäättänenPerformance of the Finnish prostate cancer screening trial based on process indicators. |
Eija SeppäläHeterogeneity in genetic susceptibility to prostate cancer. |
Outi SaramäkiGene copy number alterations in prostate cancer. |
Kimmo SavinainenAmplification and overexpression of ERBB2, uPA, TRPS1, EIF3S3 and MYC genes in prostate cancer. |
Nina MononenPolymorphisms in genes associated with androgen biosynthesis and metabolism as risk factors for human prostate cancer. |
Annika RökmanIn search of high-penetrant hereditary prostate cancer susceptibility genes in Finland. |
Kati Porkka
|
Marika LinjaAlterations in androgen receptor, estrogen receptors and their coregulatory genes in prostate cancer. |
Mika MatikainenGenetic epidemiology of hereditary prostate cancer in Finland. |
Christian PalmbergAndrogen sensitivity of prostate cancer: special reference to prognostic factors and androgen receptor gene amplification. |
Nina NupponenAmplification of EIF3S3 in breast and prostate cancer: from characterization of chromosomal alterations to identification of an amplified target gene. |
Pasi KoivistoAndrogen receptor gene amplification in hormone-refractory prostate cancer. |
Eija HyytinenMolecular cytogenetics of prostate cancer: technology development and analysis of tumor progression. |
Tapio VisakorpiCell proliferation rate in prostatic carcinomas: prognostic value and relation to epidermal growth factor receptor and p53 expression. |
Theses
Prostate cancer related dissertations completed in the Tampere University